These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31587869)

  • 21. Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.
    Elitt MS; Shick HE; Madhavan M; Allan KC; Clayton BLL; Weng C; Miller TE; Factor DC; Barbar L; Nawash BS; Nevin ZS; Lager AM; Li Y; Jin F; Adams DJ; Tesar PJ
    Stem Cell Reports; 2018 Sep; 11(3):711-726. PubMed ID: 30146490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compensating for central nervous system dysmyelination: females with a proteolipid protein gene duplication and sustained clinical improvement.
    Inoue K; Tanaka H; Scaglia F; Araki A; Shaffer LG; Lupski JR
    Ann Neurol; 2001 Dec; 50(6):747-54. PubMed ID: 11761472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.
    Henneke M; Combes P; Diekmann S; Bertini E; Brockmann K; Burlina AP; Kaiser J; Ohlenbusch A; Plecko B; Rodriguez D; Boespflug-Tanguy O; Gärtner J
    Neurology; 2008 Mar; 70(10):748-54. PubMed ID: 18094336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel PLP1 frameshift mutation causing a milder form of Pelizaeus-Merzbacher disease.
    Shiihara T; Watanabe M; Moriyama K; Uematsu M; Sameshima K
    Brain Dev; 2015 Apr; 37(4):455-8. PubMed ID: 25043250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.
    Inoue K
    Adv Exp Med Biol; 2019; 1190():201-216. PubMed ID: 31760646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling the natural history of Pelizaeus-Merzbacher disease.
    Mayer JA; Griffiths IR; Goldman JE; Smith CM; Cooksey E; Radcliff AB; Duncan ID
    Neurobiol Dis; 2015 Mar; 75():115-30. PubMed ID: 25562656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The magnetic resonance imaging spectrum of Pelizaeus-Merzbacher disease: A multicenter study of 19 patients.
    Sumida K; Inoue K; Takanashi J; Sasaki M; Watanabe K; Suzuki M; Kurahashi H; Omata T; Tanaka M; Yokochi K; Iio J; Iyoda K; Kurokawa T; Matsuo M; Sato T; Iwaki A; Osaka H; Kurosawa K; Yamamoto T; Matsumoto N; Maikusa N; Matsuda H; Sato N
    Brain Dev; 2016 Jun; 38(6):571-80. PubMed ID: 26774704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Study of
    Yan H; Yang S; Hou Y; Ali S; Escobar A; Gao K; Duan R; Kubisiak T; Wang J; Zhang Y; Xiao J; Jiang Y; Zhang T; Wu Y; Burmeister M; Wang Q; Cuajungco MP; Wang J
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype.
    Plecko B; Stöckler-Ipsiroglu S; Gruber S; Mlynarik V; Moser E; Simbrunner J; Ebner F; Bernert G; Harrer G; Gal A; Prayer D
    Neuropediatrics; 2003 Jun; 34(3):127-36. PubMed ID: 12910435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.
    Vaurs-Barrière C; Deville M; Sarret C; Giraud G; Des Portes V; Prats-Viñas JM; De Michele G; Dan B; Brady AF; Boespflug-Tanguy O; Touraine R
    Ann Neurol; 2009 Jan; 65(1):114-8. PubMed ID: 19194886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease.
    Fattal-Valevski A; DiMaio MS; Hisama FM; Hobson GM; Davis-Williams A; Garbern JY; Mahoney MJ; Kolodny EH; Pastores GM
    J Child Neurol; 2009 May; 24(5):618-24. PubMed ID: 19151366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy.
    Simons C; Dyment D; Bent SJ; Crawford J; D'Hooghe M; Kohlschütter A; Venkateswaran S; Helman G; Poll-The BT; Makowski CC; Ito Y; Kernohan K; Hartley T; Waisfisz Q; Taft RJ; ; van der Knaap MS; Wolf NI
    Brain; 2017 Dec; 140(12):3105-3111. PubMed ID: 29186371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OSCA/TMEM63 are an Evolutionarily Conserved Family of Mechanically Activated Ion Channels.
    Murthy SE; Dubin AE; Whitwam T; Jojoa-Cruz S; Cahalan SM; Mousavi SAR; Ward AB; Patapoutian A
    Elife; 2018 Nov; 7():. PubMed ID: 30382938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.
    Osorio MJ; Rowitch DH; Tesar P; Wernig M; Windrem MS; Goldman SA
    Stem Cells; 2017 Feb; 35(2):311-315. PubMed ID: 27882623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy.
    Bugiani M; Al Shahwan S; Lamantea E; Bizzi A; Bakhsh E; Moroni I; Balestrini MR; Uziel G; Zeviani M
    Neurology; 2006 Jul; 67(2):273-9. PubMed ID: 16707726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pelizaeus-Merzbacher disease as a chromosomal disorder.
    Yamamoto T; Shimojima K
    Congenit Anom (Kyoto); 2013 Mar; 53(1):3-8. PubMed ID: 23480352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease.
    Uhlenberg B; Schuelke M; Rüschendorf F; Ruf N; Kaindl AM; Henneke M; Thiele H; Stoltenburg-Didinger G; Aksu F; Topaloğlu H; Nürnberg P; Hübner C; Weschke B; Gärtner J
    Am J Hum Genet; 2004 Aug; 75(2):251-60. PubMed ID: 15192806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of curcumin in a mouse model of Pelizaeus-Merzbacher disease.
    Yu LH; Morimura T; Numata Y; Yamamoto R; Inoue N; Antalfy B; Goto Y; Deguchi K; Osaka H; Inoue K
    Mol Genet Metab; 2012 May; 106(1):108-14. PubMed ID: 22436581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Duplication of the PLP gene and the classical form of Pelizaeus-Merzbacher disease].
    Blanco-Barca MO; Eirís-Puñal J; Soler-Regal C; Castro-Gago M
    Rev Neurol; 2003 Sep 1-15; 37(5):436-8. PubMed ID: 14533091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.